Claims for Patent: 6,290,961
✉ Email this page to a colleague
Summary for Patent: 6,290,961
| Title: | Method for treating dystonia with botulinum toxin type B |
| Abstract: | A method and composition for treating a patient, suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G. |
| Inventor(s): | Aoki; K. Roger (Laguna Hill, CA), Grayston; Michael W. (Irvine, CA), Carlson; Steven R. (Laguna Niguel, CA), Leon; Judith M. (Laguna Niguel, CA) |
| Assignee: | Allergan, Inc. (Irvine, CA) |
| Application Number: | 09/490,756 |
| Patent Claims: | 1. A method for treating cervical dystonia, the method comprising the step of administering to a human patient an effective amount of botulinum toxin type B under time and
conditions to treat cervical dystonia.
2. The method of claim 1, wherein the botulinum toxin type B is administered by intramuscular injection. 3. The method of claim 1, wherein the administration of the botulinum toxin type B results in an alleviation of a symptom of the cervical dystonia within about 1 day to about 7 days. 4. The method of claim 1, wherein the patient is administered at least about 50 units of the botulinum toxin type B. 5. The method of claim 1, wherein the patient is administered at least about 1,000 units of the botulinum toxin type B. 6. A method for treating cervical dystonia, the method comprising the step of administering to a human patient an effective amount of botulinum toxin type B under time and conditions to treat cervical dystonia, wherein the botulinum toxin type B is administered by intramuscular injection, the administration of the botulinum toxin type B results in an alleviation of a symptom of the cervical dystonia within about 1 day to about 7 days and the patient is administered at least about 1,000 units of the botulinum toxin type B. 7. A method for treating cervical dystonia, the method comprising the step of administering to a human patient an effective amount of botulinum toxin type B, thereby reducing the severity of an abnormal head position symptom of cervical dystonia. 8. A method for treating cervical dystonia, the method comprising the step of administering to a human patient an effective amount of botulinum toxin type B, thereby reducing a neck pain symptom of cervical dystonia. |
Details for Patent 6,290,961
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Solstice Neurosciences, Llc | MYOBLOC | rimabotulinumtoxinb | Injection | 103846 | December 08, 2000 | 6,290,961 | 2013-12-28 |
| Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | May 07, 2001 | 6,290,961 | 2013-12-28 |
| Genzyme Corporation | LEMTRADA | alemtuzumab | Injection | 103948 | November 14, 2014 | 6,290,961 | 2013-12-28 |
| Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | October 12, 2004 | 6,290,961 | 2013-12-28 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Showing 1 to 4 of 4 entries
International Patent Family for US Patent 6,290,961
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 1516295 | ⤷ Try for Free |
| Australia | 688452 | ⤷ Try for Free |
| Australia | 7010598 | ⤷ Try for Free |
| Australia | 712502 | ⤷ Try for Free |
| Canada | 2180011 | ⤷ Try for Free |
| >Country | >Patent Number | >Estimated Expiration |
Showing 1 to 5 of 5 entries
